Stay informed about the latest updates and insights from the Conscio Group, a network of companies dedicated to improving health worldwide through quality science.
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new breast cancer treatment.
4 July 2023
Microbiology and Batch Testing: Bridging Across Sectors
Discover LVA GmbH and EL Labs s.r.o., the only Conscio Group subsidiaries at the intersection of our Pharma and Nutrition end-to-end solutions.
28 June 2023
EL Labs: Celebrating 30 Years of Analytical Milestones
Join Ján Šteso, CEO of EL Labs, as we celebrate our team's dedication, challenges overcome, and key milestones in EL's evolution.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency
15 June 2023
Novavax & Conscio: Behind the Scenes of Vaccine Development
Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.
6 June 2023
Ekolab and Conscio Group join forces
Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.
31 May 2023
Clinical Tips – Drug Interactions In Advanced Clinical Trial Design
Drug interactions play a key role in the design of clinical trials.
Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.
29 March 2023
Transdermal Patches, Films and Topicals – Putting the Skin in the Game
Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.
14 March 2023
Clinical Tips – Benefits of Sequential Designs in Bioequivalence Studies
Discover the power of sequential designs for bioequivalence studies, a crucial step in generics development: Their practical implementation, statistical analysis, and the well-being of the volunteers.
16 February 2023
A Prescription Against EU Medicine Shortages – Outsourcing Stabilities
We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.